These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 27428649)

  • 61. A competitive ELISA for the quantitative determination of the novel anti-HIV drug candidate CIGB-210 in biological fluids.
    Duarte CA; Chávez S; Masforrol Y; Puertas S; Paneque T; Ramirez AC; Casillas D; Puente P; Garay H; Fernández-Ortega C
    J Immunoassay Immunochem; 2019; 40(2):193-213. PubMed ID: 30497338
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Low-molecular-weight anti-HIV-1 agents targeting HIV-1 capsid proteins.
    Kobayakawa T; Yokoyama M; Tsuji K; Fujino M; Kurakami M; Onishi T; Boku S; Ishii T; Miura Y; Shinohara K; Kishihara Y; Ohashi N; Kotani O; Murakami T; Sato H; Tamamura H
    RSC Adv; 2023 Jan; 13(3):2156-2167. PubMed ID: 36712613
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Small-Molecule Anti-HIV-1 Agents Based on HIV-1 Capsid Proteins.
    Kobayakawa T; Yokoyama M; Tsuji K; Fujino M; Kurakami M; Boku S; Nakayama M; Kaneko M; Ohashi N; Kotani O; Murakami T; Sato H; Tamamura H
    Biomolecules; 2021 Feb; 11(2):. PubMed ID: 33546092
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Anti-HIV screening for cell-penetrating peptides using chloroquine and identification of anti-HIV peptides derived from matrix proteins.
    Mizuguchi T; Ohashi N; Nomura W; Komoriya M; Hashimoto C; Yamamoto N; Murakami T; Tamamura H
    Bioorg Med Chem; 2015 Aug; 23(15):4423-4427. PubMed ID: 26094944
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Conjugation of cell-penetrating peptides leads to identification of anti-HIV peptides from matrix proteins.
    Narumi T; Komoriya M; Hashimoto C; Wu H; Nomura W; Suzuki S; Tanaka T; Chiba J; Yamamoto N; Murakami T; Tamamura H
    Bioorg Med Chem; 2012 Feb; 20(4):1468-74. PubMed ID: 22277590
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Potent leads based on CA-19L, an anti-HIV active HIV-1 capsid fragment.
    Tsuji K; Wang R; Kobayakawa T; Owusu KB; Fujino M; Kaneko M; Yamamoto N; Murakami T; Tamamura H
    Bioorg Med Chem; 2021 Jan; 30():115923. PubMed ID: 33316719
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Exploratory studies on CA-15L, an anti-HIV active HIV-1 capsid fragment.
    Tsuji K; Owusu KB; Kobayakawa T; Wang R; Fujino M; Kaneko M; Yamamoto N; Murakami T; Tamamura H
    Bioorg Med Chem; 2020 Jun; 28(11):115488. PubMed ID: 32305183
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Development of anti-HIV peptides based on a viral capsid protein.
    Mizuguchi T; Ohashi N; Matsumoto D; Hashimoto C; Nomura W; Yamamoto N; Murakami T; Tamamura H
    Biopolymers; 2017 Jan; 108(1):. PubMed ID: 27428649
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The HIV-1 capsid protein as a drug target: recent advances and future prospects.
    Domenech R; Neira JL
    Curr Protein Pept Sci; 2013 Dec; 14(8):658-68. PubMed ID: 24106962
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The capsid protein of human immunodeficiency virus: designing inhibitors of capsid assembly.
    Neira JL
    FEBS J; 2009 Nov; 276(21):6110-7. PubMed ID: 19825045
    [TBL] [Abstract][Full Text] [Related]  

  • 71. An insight on medicinal aspects of novel HIV-1 capsid protein inhibitors.
    Sun L; Zhang X; Xu S; Huang T; Song S; Cherukupalli S; Zhan P; Liu X
    Eur J Med Chem; 2021 May; 217():113380. PubMed ID: 33751981
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Rational design of HIV-1 entry inhibitors.
    Debnath AK
    Methods Mol Biol; 2013; 993():185-204. PubMed ID: 23568472
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Interactions of HIV-1 proteins as targets for developing anti-HIV-1 peptides.
    Chandra K; Maes M; Friedler A
    Future Med Chem; 2015; 7(8):1055-77. PubMed ID: 26062401
    [TBL] [Abstract][Full Text] [Related]  

  • 74.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 75.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 76.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 4.